stars 1 stars 2 stars 3

The purpose and mission of the Mutation Analysis Core Facility (MAF) is to help scientists at Karolinska Institutet, its associated hospitals, and other academic institutions to perform genetic, epigenetic and genetic-epidemiological research in order to identify and assess genetic factors involved in different disease processes. Single nucleotide polymorphism (SNP) genotyping has been offered since 2003 and from 2010 we also perform targeted epigenetic analyses with the Agena MALDI-TOF technique. We also carry out genome wide analysis using the Illumina iScan platform. There is a broad portfolio of Beadchips for the system which encompasses: genotyping, CNV analysis, and DNA methylation. MAF has an accreditation of its organization, facilities and the Agena genotyping and DNA methylation analysis methods according to ISO/IEC 17025 by SWEDAC.

Mutation Analysis Facility (MAF) Questions

The Mutation Analysis Facility (MAF) annual revenue was $851.5 million in 2026.

Mutation Analysis Facility (MAF) is based in Huddinge, Stockholm County.

G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users